Crisis and opportunity often go hand in hand, as the saying goes. But nowhere has that sentiment more aptly been applied than the life sciences sector, which has found itself thrust into the public limelight these past 18 months. 

Lawyers have found themselves on the cutting edge of vaccine development, brought in to assist governments on emergency responses and facilitate all manner of legal quandaries at the forefront of the global battle against COVID-19.